Please login to the form below

Not currently logged in

Smart Thinking blog

Insights and expert advice on the key issues facing today’s pharma marketer

Social innovation in pharma

The use of social media by pharma beyond Facebook and Twitter

We tend to judge how well pharmaceutical companies are doing in social media by analysing their presence on Facebook, Twitter and YouTube. But there are many other ways of using social media that should be added to the equation, including the use of what is described as social innovation. 

According to Wikipedia, “social media refers to the means of interactions among people in which they create, share, and exchange information and ideas in in virtual communities and networks”. Of course, this includes Facebook and Twitter as social and microblogging networks, but it also comprises social bookmarking, wikis, virtual social worlds and crowdsourcing, to name a few. And all of this can work in an open community or within a closed and restricted set of people (eg, employees of a particular company or registered healthcare practitioners).

There are plenty of internal social media projects in pharma that can rival any other sector. Enterprise social networks may be a good example. Yammer is being used by three of the top 10 pharmaceutical companies while many others are using the social features of Microsoft SharePoint to increase collaboration and teamworking amongst their employees. 

Several years ago, Pfizer went further and implemented an internal social innovation network based on Spigit technology. Any Pfizer employee could post new ideas related or not to their area of expertise. They could discuss, improve and rate ideas posted by others, and, finally, an innovation board assessed the feasibility and business impact of the best ones and decided on how to implement them. This was a very successful project that evolved and became organised around innovation communities.

Social innovation becomes much more effective when it is opened to the external world, and your customers can be part of the process. This is called crowdsourcing innovation or open innovation and one of the most popular examples of any sector is 'My Starbucks Idea', a website where the coffee company invites its customers to shape the future of Starbucks together. 

You may wonder if any pharma company is using the open innovation approach, as this sector has a tradition of caginess and conservatism. The answer is yes indeed. Lilly pioneered it with its Open Innovation Drug Discovery, a place where Lilly's scientists connect with external investigators to discover new drugs together. This this seems to be the way forward for more and more drug development firms. In 2012, a new startup called Transparency Life Sciences (TLS) claimed to be “the world's first drug development company based on open innovation”. That is, they only work in an open and social environment. Their focus is on the design of clinical trials, their execution and analysis by using what they call “collaborative intelligence”. Anyone, anywhere, can contribute to the planning and design of TLS compound development strategies and tactics in real time.

As set out above, there are other ways of using social media beyond trying to get more followers in the most conspicuous social networks. Engaging employees and customers with social innovation can be a very interesting and productive approach, and many pharmaceutical companies are already doing so.

Article by
Antonio Ibarra

multichannel marketing manager, Sanofi Pasteur MSD

18th February 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Four MSA

Four MSA creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal approach....

Latest intelligence

White paper download: Creating experiences to improve patient outcomes
Download our white paper "Creating experiences to improve patient outcomes" to learn the steps to building an effective customer experience strategy....
Organisational Memory
In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding...
Thoughts on the intersection between technology and psychology
Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology...